Department of Medical Physics, Hospital La Princesa, Health Research Institute IIS-IP, Diego de León 62, 28006, Madrid, Spain.
Department of Radiation Oncology, Hospital La Princesa, IIS-IP, Madrid, Spain.
Clin Transl Oncol. 2021 Nov;23(11):2293-2301. doi: 10.1007/s12094-021-02628-3. Epub 2021 Apr 28.
The objective of this study was to evaluate the dosimetric impact on hypofractionated prostate radiation therapy of two geometric uncertainty sources: rectum and bladder filling and intrafractional prostate motion.
This prospective study included 544 images (375 pre-treatment cone-beam CT [CBCT] and 169 post-treatment CBCT) from 15 prostate adenocarcinoma patients. We recalculated the dose on each pre-treatment CBCT once the positioning errors were corrected. We also recalculated two dose distributions on each post-treatment CBCT, either using or not intrafractional motion correction. A correlation analysis was performed between CBCT-based dose and rectum and bladder filling as well as intrafraction prostate displacements.
No significant differences were found between administered and planned rectal doses. However, we observed an increase in bladder dose due to a lower bladder filling in 66% of treatment fractions. These differences were reduced at the end of the fraction since the lower bladder volume was compensated by the filling during the treatment session. A statistically significant reduction in target volume coverage was observed in 27% of treatment sessions and was correlated with intrafractional prostate motion in sagittal plane > 4 mm.
A better control of bladder filling is recommended to minimize the number of fractions in which the bladder volume is lower than planned. Fiducial mark tracking with a displacement threshold of 5 mm in any direction is recommended to ensure that the prescribed dose criteria are met.
本研究旨在评估两种几何不确定性源(直肠和膀胱充盈度以及分次内前列腺运动)对前列腺短分割放射治疗的剂量学影响。
这项前瞻性研究纳入了 15 例前列腺腺癌患者的 544 幅图像(375 幅治疗前锥形束 CT [CBCT]和 169 幅治疗后 CBCT)。我们在纠正定位误差后,重新计算了每个治疗前 CBCT 的剂量。我们还分别在每个治疗后 CBCT 上使用或不使用分次内运动校正,重新计算了两个剂量分布。我们对基于 CBCT 的剂量与直肠和膀胱充盈度以及分次内前列腺位移之间进行了相关性分析。
实际给予的直肠剂量与计划直肠剂量之间无显著差异。然而,我们观察到 66%的治疗分数中由于膀胱充盈度较低而导致膀胱剂量增加。由于在治疗过程中膀胱体积的填充,这种差异在分次结束时得到了缓解。在 27%的治疗中观察到目标体积覆盖率的显著降低,这与矢状面的分次内前列腺运动大于 4mm 有关。
建议更好地控制膀胱充盈度,以减少膀胱体积低于计划的治疗分数数量。建议使用标记物跟踪技术,并设置 5mm 的位移阈值,以确保满足规定的剂量标准。